Zobrazeno 1 - 10
of 176
pro vyhledávání: '"N V Chichasova"'
Autor:
A S Avdeeva, M V Cherkasova, D A Kusevich, V V Rybakova, A S Artyuhov, Eh B Dashinimaev, N V Chichasova, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 91, Iss 5, Pp 26-33 (2019)
Aim: to evaluate the role of laboratory biomarkers in monitoring effectiveness of rituximab (RTM) biosimilar therapy in a total dose of 1200 mg. Materials and methods. 20 patients (pts) with rheumatoid arthritis (RA) (18 woman, mean age 61.5(54-66.5)
Externí odkaz:
https://doaj.org/article/c28b0e98ea46440eb5eb3cdfd06c3078
Publikováno v:
Современная ревматология, Vol 8, Iss 1, Pp 31-38 (2014)
Idiopathic inflammatory myopathies (IIM) are rare disorders characterized by inflammatory lesions in skeletal muscles. These diseases include polymyositis (PM), dermatomyositis (DM), and inclusion body myositis, which exhibit clinicoimmunological het
Externí odkaz:
https://doaj.org/article/4fbd9a786d97467399316f8ec751a7af
Publikováno v:
Научно-практическая ревматология, Vol 52, Iss 1, Pp 8-26 (2014)
In our previous publication, we reported the main provisions of the new EULAR recommendations (2013) and discussed some debating points of RA pharmacotherapy that require further research. The purpose of this article is to review the present-day know
Externí odkaz:
https://doaj.org/article/394a883b1a3544698a6b101fa5d0101c
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 6, Pp 609-22 (2014)
There has been significant progress in research focused on rheumatoid arthritis (RA) over the past decade. Nine innovative biologics agents – monoclonal antibodies and recombinant proteins inhibiting activity of the key proinflammatory cytokines an
Externí odkaz:
https://doaj.org/article/e996a722be364da2aa9d5850e9c2c6d9
Autor:
Lyudmila Ivanovna Alekseeva, E P Sharapova, E A Taskina, N V Chichasova, G R Imametdinova, N A Shostak, N G Pravdyuk, L N Denisov
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 5, Pp 532-538 (2013)
Objective: to evaluate the symptom- and structure-modifying effect of alflutop versus placebo (PL) in patients with knee osteoarthrosis (OA).Subjects and methods. The trial enrolled 90 patients with knee OA (ACR criteria and Kellgren–Lawrence Stage
Externí odkaz:
https://doaj.org/article/290cc7bc396741f98b558537a96dfc5c
Autor:
N. V. Chichasova, A. M. Lila
Publikováno v:
Современная ревматология, Vol 18, Iss 4, Pp 106-114 (2024)
This review presents the latest data on the long-term use of the selective Janus kinase inhibitor (JAKi) baricitinib (BARI) in patients with rheumatoid arthritis (RA) in real-world clinical practice. The results of long-term use (up to 9.5 years) of
Externí odkaz:
https://doaj.org/article/634356a62607463e8e7b1472e041f6df
Publikováno v:
Современная ревматология, Vol 0, Iss 1, Pp 59-65 (2013)
The paper considers problems in the treatment of acute and chronic pain in patients with rheumatic diseases and shows the role of inflammation and muscle spasm in the pathogenesis of acute and chronic pain. It gives the results of clinical trials and
Externí odkaz:
https://doaj.org/article/75a98f3f0253417a8c510ec30ce01b05
Autor:
N V Chichasova
Publikováno v:
Остеопороз и остеопатии, Vol 14, Iss 2, Pp 32-36 (2011)
Клиническое обоснование применения различно. Дано клиническое обоснование использования у больных остеоартрозом (ОА) препарата Терафл
Externí odkaz:
https://doaj.org/article/ba01342db6444f32a25bc0df38eb723f
Publikováno v:
Современная ревматология, Vol 4, Iss 4, Pp 66-70 (2010)
The paper depicts the aspects of symptomatic therapy for chronic inflammatory diseases of joints and the mechanisms of action of nonsteroidal anti-inflammatory drugs. It gives the data available in the literature on the efficacy of Voltaren (diclofen
Externí odkaz:
https://doaj.org/article/29dd38a28be445b6a82447e6e3f367f8
Autor:
N V Chichasova, E L Nasonov
Publikováno v:
Современная ревматология, Vol 4, Iss 1, Pp 46-58 (2010)
The paper reviews the current trials of the safety of using genetic engineering biological agents (GEBA) in patients with rheumatoid arthritis. It is stated that before its start, GEBA therapy calls for thorough screening of patients to rule out comm
Externí odkaz:
https://doaj.org/article/1740392211b349e4b2fdfd55b7eeb3bb